Found: 144
Select item for more details and to access through your institution.
PSA doubling time 4.65 months as an optimal cut-off of Japanese nonmetastatic castration-resistant prostate cancer.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-65969-3
- By:
- Publication type:
- Article
Arterio–ureteral fistula from a pseudoaneurysm of the right common iliac artery after robot‐assisted laparoscopic radical cystectomy: A case report.
- Published in:
- Asian Journal of Endoscopic Surgery, 2024, v. 17, n. 3, p. 1, doi. 10.1111/ases.13348
- By:
- Publication type:
- Article
The lymphocyte-to-monocyte ratio as a significant inflammatory marker associated with survival of patients with metastatic renal cell carcinoma treated using nivolumab plus ipilimumab therapy.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 7, p. 1019, doi. 10.1007/s10147-024-02538-8
- By:
- Publication type:
- Article
Prognostication in Lymph Node-Positive Prostate Cancer with No PSA Persistence After Radical Prostatectomy.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2024, v. 31, n. 6, p. 3872, doi. 10.1245/s10434-024-14999-2
- By:
- Publication type:
- Article
Validation study on the 2 mm diameter cutoff in lymph node‐positive cases following radical prostatectomy in accordance with the AJCC/UICC TNM 8th edition: Real‐world data analysis from a Japanese cohort.
- Published in:
- International Journal of Urology, 2024, v. 31, n. 6, p. 662, doi. 10.1111/iju.15434
- By:
- Publication type:
- Article
Androgen deprivation therapy caused a drastic proliferation of B-cell lymphoma with IgG4-related disease in patients with prostate cancer: a case report.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 16, p. 15091, doi. 10.1007/s00432-023-05292-y
- By:
- Publication type:
- Article
Real clinical outcomes of nivolumab plus ipilimumab for renal cell carcinoma in patients over 75 years old.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 11, p. 1530, doi. 10.1007/s10147-023-02394-y
- By:
- Publication type:
- Article
Trends in the use of local intervention for metastatic hormone‐naïve prostate cancer: A multicenter retrospective study.
- Published in:
- International Journal of Urology, 2023, v. 30, n. 11, p. 969, doi. 10.1111/iju.15240
- By:
- Publication type:
- Article
Increasing age predicts adverse pathology including intraductal carcinoma of the prostate and cribriform patterns in deferred radical prostatectomy after upfront active surveillance for Gleason grade group 1 prostate cancer: analysis of prospective observational study cohort
- Published in:
- Japanese Journal of Clinical Oncology, 2023, v. 53, n. 10, p. 984, doi. 10.1093/jjco/hyad088
- By:
- Publication type:
- Article
The Current Trend of Radiation Therapy for Patients with Localized Prostate Cancer.
- Published in:
- Current Oncology, 2023, v. 30, n. 9, p. 8092, doi. 10.3390/curroncol30090587
- By:
- Publication type:
- Article
Primary resistance to nivolumab plus ipilimumab therapy in patients with metastatic renal cell carcinoma.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 16, p. 16837, doi. 10.1002/cam4.6306
- By:
- Publication type:
- Article
Combination of docetaxel versus nonsteroidal antiandrogen with androgen deprivation therapy for high-volume metastatic hormone-sensitive prostate cancer: a propensity score-matched analysis.
- Published in:
- World Journal of Urology, 2023, v. 41, n. 8, p. 2051, doi. 10.1007/s00345-022-04030-2
- By:
- Publication type:
- Article
Docetaxel versus abiraterone for metastatic hormone‐sensitive prostate cancer with focus on efficacy of sequential therapy.
- Published in:
- Prostate, 2023, v. 83, n. 6, p. 563, doi. 10.1002/pros.24488
- By:
- Publication type:
- Article
Genetic variations predicting progression with docetaxel and novel androgen‐receptor pathway inhibitors.
- Published in:
- Cancer Science, 2023, v. 114, n. 4, p. 1625, doi. 10.1111/cas.15718
- By:
- Publication type:
- Article
The efficacy of sequential therapy with docetaxel and cabazitaxel for castration‐resistant prostate cancer: A retrospective multi‐institutional study in Japan.
- Published in:
- International Journal of Urology, 2023, v. 30, n. 2, p. 227, doi. 10.1111/iju.15097
- By:
- Publication type:
- Article
BRCA2 Frameshift Mutation in de novo Small-Cell Neuroendocrine Carcinoma of the Prostate: A Case Report.
- Published in:
- Case Reports in Oncology, 2023, v. 16, n. 1, p. 621, doi. 10.1159/000531134
- By:
- Publication type:
- Article
Impact of trough abiraterone level on adverse events in patients with prostate cancer treated with abiraterone acetate.
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 1, p. 89, doi. 10.1007/s00228-022-03420-0
- By:
- Publication type:
- Article
Comparison of efficacy and medical costs between upfront docetaxel and abiraterone treatments of metastatic hormone-sensitive prostate cancer patients in real-world practice: a multicenter retrospective study.
- Published in:
- World Journal of Urology, 2023, v. 41, n. 1, p. 67, doi. 10.1007/s00345-022-04237-3
- By:
- Publication type:
- Article
Impact of germline HLA genotypes on clinical outcomes in patients with urothelial cancer treated with pembrolizumab.
- Published in:
- Cancer Science, 2022, v. 113, n. 12, p. 4059, doi. 10.1111/cas.15488
- By:
- Publication type:
- Article
Prevalence and risk estimation of cancer-predisposing genes for upper urinary tract urothelial carcinoma in Japanese.
- Published in:
- Japanese Journal of Clinical Oncology, 2022, v. 52, n. 12, p. 1441, doi. 10.1093/jjco/hyac141
- By:
- Publication type:
- Article
Prognostic significance of pathogenic variants in BRCA1, BRCA2, ATM and PALB2 genes in men undergoing hormonal therapy for advanced prostate cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Cancer‐specific and net overall survival in older patients with de novo metastatic prostate cancer initially treated with androgen deprivation therapy.
- Published in:
- International Journal of Urology, 2022, v. 29, n. 10, p. 1147, doi. 10.1111/iju.14938
- By:
- Publication type:
- Article
Does castration status affect docetaxel‐related adverse events? :Identification of risk factors for docetaxel‐related adverse events in metastatic prostate cancer.
- Published in:
- Prostate, 2022, v. 82, n. 14, p. 1322, doi. 10.1002/pros.24406
- By:
- Publication type:
- Article
Effect of upfront intensive therapy on oncological outcomes in older patients with high tumor burden metastatic castration‐sensitive prostate cancer: A multicenter retrospective study.
- Published in:
- Prostate, 2022, v. 82, n. 13, p. 1304, doi. 10.1002/pros.24404
- By:
- Publication type:
- Article
Real-world outcomes and risk stratification in patients with metastatic castration-sensitive prostate cancer treated with upfront abiraterone acetate and docetaxel.
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 9, p. 1477, doi. 10.1007/s10147-022-02203-y
- By:
- Publication type:
- Article
Impact of histological variants on outcomes in patients with urothelial carcinoma treated with pembrolizumab: a propensity score matching analysis.
- Published in:
- BJU International, 2022, v. 130, n. 2, p. 226, doi. 10.1111/bju.15510
- By:
- Publication type:
- Article
Radiotherapy plus androgen deprivation therapy for prostate‐specific antigen persistence in lymph node–positive prostate cancer.
- Published in:
- Cancer Science, 2022, v. 113, n. 7, p. 2386, doi. 10.1111/cas.15383
- By:
- Publication type:
- Article
Machine learning diagnosis by immunoglobulin N‐glycan signatures for precision diagnosis of urological diseases.
- Published in:
- Cancer Science, 2022, v. 113, n. 7, p. 2434, doi. 10.1111/cas.15395
- By:
- Publication type:
- Article
Severe Immune-Related Adverse Events in Patients Treated with Nivolumab for Metastatic Renal Cell Carcinoma Are Associated with PDCD1 Polymorphism.
- Published in:
- Genes, 2022, v. 13, n. 7, p. 1204, doi. 10.3390/genes13071204
- By:
- Publication type:
- Article
Overview of clinical management for older patients with renal cell carcinoma.
- Published in:
- Japanese Journal of Clinical Oncology, 2022, v. 52, n. 7, p. 657, doi. 10.1093/jjco/hyac047
- By:
- Publication type:
- Article
Different risk genes contribute to clear cell and non-clear cell renal cell carcinoma in 1532 Japanese patients and 5996 controls.
- Published in:
- Human Molecular Genetics, 2022, v. 31, n. 12, p. 1962, doi. 10.1093/hmg/ddab345
- By:
- Publication type:
- Article
Factors influencing warm ischemia time in robot-assisted partial nephrectomy change depending on the surgeon's experience.
- Published in:
- World Journal of Surgical Oncology, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s12957-022-02669-0
- By:
- Publication type:
- Article
Management of prostate cancer in older patients.
- Published in:
- Japanese Journal of Clinical Oncology, 2022, v. 52, n. 6, p. 513, doi. 10.1093/jjco/hyac016
- By:
- Publication type:
- Article
Real-world survival outcomes of adding docetaxel or abiraterone in patients with high-volume metastatic castration-sensitive prostate cancer: historically controlled, propensity score matched comparison with androgen deprivation therapy.
- Published in:
- World Journal of Urology, 2022, v. 40, n. 5, p. 1135, doi. 10.1007/s00345-022-03963-y
- By:
- Publication type:
- Article
Perinatal Management in a Pregnant Woman with Ureteropelvic Junction Obstruction: Case Report and Literature Review.
- Published in:
- Diagnostics (2075-4418), 2022, v. 12, n. 4, p. 913, doi. 10.3390/diagnostics12040913
- By:
- Publication type:
- Article
Impact of Gleason pattern 5 on prognosis for newly diagnosed metastatic hormone‐sensitive prostate cancer with Gleason score ≥8.
- Published in:
- International Journal of Urology, 2022, v. 29, n. 4, p. 324, doi. 10.1111/iju.14781
- By:
- Publication type:
- Article
Prognostic impact of proton pump inhibitors for immunotherapy in advanced urothelial carcinoma.
- Published in:
- BJUI Compass, 2022, v. 3, n. 2, p. 154, doi. 10.1002/bco2.118
- By:
- Publication type:
- Article
Effect of HLA genotype on intravesical recurrence after bacillus Calmette–Guérin therapy for non-muscle-invasive bladder cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 3, p. 727, doi. 10.1007/s00262-021-03032-0
- By:
- Publication type:
- Article
Management of bladder cancer in older patients.
- Published in:
- Japanese Journal of Clinical Oncology, 2022, v. 52, n. 3, p. 203, doi. 10.1093/jjco/hyab187
- By:
- Publication type:
- Article
Specific Gut Microbial Environment in Lard Diet-Induced Prostate Cancer Development and Progression.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 4, p. 2214, doi. 10.3390/ijms23042214
- By:
- Publication type:
- Article
Clinical Utility of Germline Genetic Testing in Japanese Men Undergoing Prostate Biopsy.
- Published in:
- JNCI Cancer Spectrum, 2022, v. 6, n. 1, p. 1, doi. 10.1093/jncics/pkac001
- By:
- Publication type:
- Article
Comparison of parenchymal volume loss assessed by three‐dimensional computed tomography volumetry and renal functional recovery between conventional and robot‐assisted laparoscopic partial nephrectomy.
- Published in:
- Asian Journal of Endoscopic Surgery, 2022, v. 15, n. 1, p. 63, doi. 10.1111/ases.12966
- By:
- Publication type:
- Article
Altering phosphoinositides in high-fat diet-associated prostate tumor xenograft growth.
- Published in:
- MedComm, 2021, v. 2, n. 4, p. 756, doi. 10.1002/mco2.89
- By:
- Publication type:
- Article
Characteristics of α2,3‐sialyl N‐glycosylated PSA as a biomarker for clinically significant prostate cancer in men with elevated PSA level.
- Published in:
- Prostate, 2021, v. 81, n. 16, p. 1411, doi. 10.1002/pros.24239
- By:
- Publication type:
- Article
Incidence, Etiology, Prevention and Management of Ureteroenteric Strictures after Robot-Assisted Radical Cystectomy: A Review of Published Evidence and Personal Experience.
- Published in:
- Current Oncology, 2021, v. 28, n. 5, p. 4109, doi. 10.3390/curroncol28050348
- By:
- Publication type:
- Article
Prognosis of Japanese metastatic renal cell carcinoma patients in the targeted therapy era.
- Published in:
- International Journal of Clinical Oncology, 2021, v. 26, n. 10, p. 1947, doi. 10.1007/s10147-021-01979-9
- By:
- Publication type:
- Article
Impact of Nerve-Sparing Status on Positive Surgical Margin Location and Biochemical Recurrence in Patients with Prostate Cancer Post Radical Prostatectomy.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2021, v. 28, n. 9, p. 5341, doi. 10.1245/s10434-021-10281-x
- By:
- Publication type:
- Article
Comparison of pembrolizumab with conventional chemotherapy after first‐line platinum‐based chemotherapy for advanced urothelial carcinoma in real‐world practice: A multicenter retrospective study.
- Published in:
- International Journal of Urology, 2021, v. 28, n. 9, p. 899, doi. 10.1111/iju.14601
- By:
- Publication type:
- Article
Impact of pretreatment anemia on upfront abiraterone acetate therapy for metastatic hormone-sensitive prostate cancer: a multicenter retrospective study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Macrophage inhibitory cytokine‐1 induced by a high‐fat diet promotes prostate cancer progression by stimulating tumor‐promoting cytokine production from tumor stromal cells.
- Published in:
- Cancer Communications, 2021, v. 41, n. 5, p. 389, doi. 10.1002/cac2.12137
- By:
- Publication type:
- Article